Answers are grounded in this paper and cite their sources.
Clinical evidence supports enhanced diabetes screening through corneal aesthesiometry, indicating potential benefits.
Recent clinical evidence that dimnished corneal sensitivity occurs far more frequently (p < 0.003) among diabetics than nondibetics, supports the addition of aestbesometry to the routine optometric screening battery for patients at risk of diabetes. This evidence is reviewed and quantitative estimates are presented to illustrate the clinical efficacy of this screening test.
No takes yet. Share an insight, caveat, or question.
J. G. Daubs (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: